Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,80119,820 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Development of next generation 2HG and metabolic MR imaging for precision oncology of mutant IDH and wildtype glioma patients
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

7. Project Summary/Abstract Gliomas are rarely curable tumors with a low survival rate of 36% at five-years that is well below the average survival rate of 67.2% across all cancers...

$6.45M
USD
Completed NON-SBIR/STTR RPGS
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
NATIONAL CANCER INSTITUTE Purdue University United States 2021 – 2026

ABSTRACT Head and neck cancer is currently treated by concomitant chemotherapy and radiation, but local recurrence and metastatic disease remain a concern. In particular, there is...

$5.6M
USD
Completed NON-SBIR/STTR RPGS
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDA) is the fourth lethal cancer in the U.S. with a 5-year survival rate of only ~10%. The mainstay of therapy in PDA is chemother...

$3.8M
USD
Completed NON-SBIR/STTR RPGS
Targeting MUC5AC mucin in breast cancer brain metastasis
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2021 – 2026

Abstract Breast cancer (BC) brain/central nervous system (CNS) metastasis is associated with poor survival among U.S. women, with 30-40% of these cases reported as triple receptor-...

$4.38M
USD
Completed NON-SBIR/STTR RPGS
Imaging Modulation of Immune Phenotype
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Imaging and modulation of immunophenotype Most importantly, we have created TLR delivery nanotherapeutics and find that TLR NPs combined with aCD40, aPD-1 and aCTL4 (abbreviated as...

$6.21M
USD
Completed NON-SBIR/STTR RPGS
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Project Summary Cancer and cardiovascular disease are leading causes of death in the United States. Given the high percentage of cancer patients with co-existing atherosclerosis, t...

$1.5M
USD
Completed NON-SBIR/STTR RPGS
Discovering the role of YES1 in triple negative breast cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT SRC Family Kinases (SFKs) are a group of 9 non-receptor tyrosine kinases that mediate the effects of many extracellular and intracellular signaling pathway...

$4.52M
USD
Completed TRAINING, INDIVIDUAL
Role of phosphate availability in lung cancer invasion and bone metastasis
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2024

PROJECT SUMMARY Metastatic dissemination is a leading cause of death from cancer with metastasis to bone represents a particularly poor prognosis. Unfortunately, metastasis to bone...

$808K
USD
Completed TRAINING, INDIVIDUAL
Development of a tumor-activated IL12 prodrug to treat solid tumors
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary/Abstract: Despite recent advances in cancer immunotherapy, solid tumors remain largely refractory to treatment due to disruption of immune homeostasis by the tumor...

$517.5K
USD
Completed TRAINING, INDIVIDUAL
Dysregulation of Liver Macrophages in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is the third-leading cause of cancer-related deaths in the United States. Metastasis is the major cause of mortality for pat...

$341K
USD
Completed TRAINING, INDIVIDUAL
Role of phosphate availability in lung cancer invasion and bone metastasis
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2024

PROJECT SUMMARY Metastatic dissemination is a leading cause of death from cancer with metastasis to bone represents a particularly poor prognosis. Unfortunately, metastasis to bone...

$785.5K
USD
Completed NON-SBIR/STTR RPGS
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2026

Project Summary/Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood. Despite rigorous clinical trials the survival for children with high-risk RMS h...

$4.02M
USD
Completed NON-SBIR/STTR RPGS
Deciphering the molecular control of intratumoral dendritic cells
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY Dendritic cells (DC) have a major influence on tumor immunity. DC depletion abrogates tumor immunity and response to PD1 (αPD1) immunotherapy in many preclinical tu...

$5.36M
USD
Completed NON-SBIR/STTR RPGS
Targeting immune suppressive microenvironment in ATC
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Patients with anaplastic thyroid cancer (ATC) have a median survival of 6 months. Chemotherapy in combination with surgery and radiation may modestly exten...

$4.32M
USD
Completed TRAINING, INDIVIDUAL
T cell mechanisms of immunotherapy response in pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

Project Summary Immune checkpoint inhibitors (ICIs) provide durable clinical responses in about 20% of cancer patients, but have been largely ineffective for non-immunogenic cancer...

$460.4K
USD
Completed TRAINING, INDIVIDUAL
Tracing Intratumoral Cellular Heterogeneity using genetic barcoding in small cell lung cancer
NATIONAL CANCER INSTITUTE University of South Dakota United States 2021 – 2024

PROJECT SUMMARY Tumors are often highly heterogeneous, with a number of functionally different cells existing within a single tumor, giving some cells the ability to initiate new t...

$393.2K
USD
Completed OTHER RESEARCH-RELATED
Improving sleep in gynecologic cancer survivors
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2021

PROJECT SUMMARY Sleep disturbance is one of the primary complaints of gynecologic cancer survivors, with more than 80% of survivors reporting sleep difficulties. Sleep disturbance...

$1.77M
USD
Completed OTHER RESEARCH-RELATED
Cancer misinformation on social media and its correction
NATIONAL CANCER INSTITUTE Northeastern University United States 2021 – 2023

Project Summary The overarching goal of this study is to measure the prevalence of cancer misinformation on social media and understand the mechanisms that underlies its spread.Bel...

$1.54M
USD
Completed NON-SBIR/STTR RPGS
Targeting B7-H3 in ovarian cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

ABSTRACT Remarkable clinical responses have been reported in B-cell malignancies by adoptive transfer of T cells redirected with a chimeric antigen receptor (CAR) specific for the...

$6.32M
USD
Completed TRAINING, INDIVIDUAL
Reducing the Burden of Hepatocellular Carcinoma Among Migrant Populations: Improving prevention and outcomes through disease modeling
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2025

Project Summary Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer mortality in the United States.HCC is preventable, and it disproportionately affects migrants...

$462.4K
USD